Despite its widespread use in AKI in cirrhotic patients, the optimal albumin dose is uncertain, and one should be particularly vigilant about the possibility of iatrogenic pulmonary edema with the use of higher doses. The gene discussed is ALB; the disease is acute kidney injury.